superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
- Valid from
- 2024-12-31
- Valid until
- 2025-12-31
- Published
- 2025-02-05
- Recorded by AsOf
- 2026-11-08
- Checked
- 2026-11-08 · parsed from the SEC filing
- Confidence
- 0.95
- Replaced by
- 127,658,000,000 DKK
Sources
Cite this claim
Plain text
AsOf. "Novo Nordisk operating income: 128,339,000,000 DKK", as of 2024-12-31 (until 2025-12-31). Claim clm_109041F6F3C0, https://asof.is/claim/clm_109041F6F3C0, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/353278/000162828025003920/0001628280-25-003920-index.htm.
APA
AsOf. (2024). Novo Nordisk operating income: 128,339,000,000 DKK (as of 2024-12-31 (until 2025-12-31)) [Record clm_109041F6F3C0]. Retrieved November 9, 2026, from https://asof.is/claim/clm_109041F6F3C0 (source: https://www.sec.gov/Archives/edgar/data/353278/000162828025003920/0001628280-25-003920-index.htm)
BibTeX
@misc{asof_clm_109041F6F3C0,
author = {AsOf},
title = {Novo Nordisk operating income: 128,339,000,000 DKK},
year = {2024},
howpublished = {\url{https://asof.is/claim/clm_109041F6F3C0}},
note = {Claim clm\_109041F6F3C0, as of 2024-12-31 (until 2025-12-31); source: https://www.sec.gov/Archives/edgar/data/353278/000162828025003920/0001628280-25-003920-index.htm},
urldate = {2026-11-09}
}Supersedes
On the record
/claim/clm_109041F6F3C0.md/v1/claims/clm_109041F6F3C0submit a correction